/
The Company is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The Company is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers.
15.32% operating margin is respectable but not wide. ROIC at 13.86%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 19.5%, still solid.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$609M
▲ +19.5% YoY
Net Income (TTM)
$69M
▲ +15.8% YoY
Op. Margin
15.21%
▼ -0.7pp YoY
ROIC
13.40%
▼ -1.3pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$81M
▲ +38.0% YoY
Net Debt
$136M
Cash & Equiv.
$20M
5Y CAGR: +27.4%
5Y CAGR: +17.5%
Continue Research